Literature DB >> 11328469

Leucocyte populations in respiratory syncytial virus-induced bronchiolitis.

P K Smith1, S Z Wang, K D Dowling, K D Forsyth.   

Abstract

OBJECTIVES: To enumerate the cellular composition of the airways in infants with acute bronchiolitis.
METHODOLOGY: Cells were obtained by airway lavage from the upper and lower airway and the peripheral blood of infants with respiratory syncytial virus (RSV)+ bronchiolitis, RSV- bronchiolitis and age-matched controls.
RESULTS: Neutrophils are the predominant cells present in the upper and lower airway. Neutrophils are present at a higher number/unit volume in the airway than in the peripheral blood.
CONCLUSIONS: Neutrophils, being the dominant cellular infiltrate into the airway, are likely to contribute to the pathophysiology of bronchiolitis. Therapies targeted at limiting neutrophil influx or neutrophil-mediated damage in the airway may have a therapeutic role.

Entities:  

Mesh:

Year:  2001        PMID: 11328469     DOI: 10.1046/j.1440-1754.2001.00618.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  47 in total

1.  Dipeptidyl peptidase I-dependent neutrophil recruitment modulates the inflammatory response to Sendai virus infection.

Authors:  Antonina M Akk; Pamela M Simmons; Happy W Chan; Eugene Agapov; Michael J Holtzman; Mitchell H Grayson; Christine T N Pham
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 2.  Early identification of atopy in the prediction of persistent asthma in children.

Authors:  Peter D Sly; Attilio L Boner; Bengt Björksten; Andy Bush; Adnan Custovic; Philippe A Eigenmann; James E Gern; Jorrit Gerritsen; Eckard Hamelmann; Peter J Helms; Robert F Lemanske; Fernando Martinez; Soren Pedersen; Harald Renz; Hugh Sampson; Erika von Mutius; Ulrich Wahn; Patrick G Holt
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

3.  Respiratory syncytial virus and neutrophil activation.

Authors:  E L Bataki; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection.

Authors:  Junyan Han; Katsuyuki Takeda; Meiqin Wang; Wanjiang Zeng; Yi Jia; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2014-07       Impact factor: 6.914

Review 5.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

6.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

7.  Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis.

Authors:  P S McNamara; P Ritson; A Selby; C A Hart; R L Smyth
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

8.  Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.

Authors:  A Jones; I Morton; L Hobson; G S Evans; M L Everard
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

9.  Cytokine responses in primary and secondary respiratory syncytial virus infections.

Authors:  Kelechi Ugonna; Konstantinos Douros; Colin D Bingle; Mark L Everard
Journal:  Pediatr Res       Date:  2016-02-16       Impact factor: 3.756

Review 10.  Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells.

Authors:  Tanya A Miura; Kathryn V Holmes
Journal:  J Leukoc Biol       Date:  2009-07-28       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.